Panel Discussion: Early Stage Characterization & Analysis of Cellular Therapeutics

Time: 2:30 pm
day: Day 1 Track 1 AM


  • What is the best strategy to characterize cell therapies when their dynamism makes it impossible to fully characterize all properties and functions?
  • Given each assay only reveals a limited number of attributes, how many assays do we need to fully characterize our cell products?
  • How do we select the most appropriate cellular attribute?